Biomarkers of Reaction To HIIT Exercise

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-89
SponsorVA Office of Research and Development

About this trial

Stroke survivors with lower limb disability can improve their walking speed with high-intensity interval training (HIIT) rehabilitation therapy. However, some individuals may not respond to HIIT even when fully adherent to the program. To address this, the investigators propose to build a predictive model that identifies if a Veteran with chronic subcortical stroke will improve their walking speed with HIIT by incorporating blood lactate as an early predictor of exercise response, and inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and regional cerebral blood flow (CBF) as predictors of the brain's potential to respond, while also taking into consideration other factors such as comorbidities, demographics, and fitness levels.

Eligibility criteria

Qualifiers

chronic left or right subcortical stroke as defined by 6 months or more after a cardiovascular accident

lower extremity motor impairment due to stroke that causes a walking speed of less than 0.6 m/s during a 10m walk

Veteran status

Disqualifiers

MRI contraindications, including implanted cardiac pacemakers and severe claustrophobia

any neurodegenerative condition other than stroke that may lead to lower extremity impairment

a visual or auditory impairment that may hinder study procedures

any medical condition that would preclude participation in a physical exercise intervention program

Trial design

Treatments tested in this trial

  • High Intensity Interval Training (HIIT)

Treatment groups

55 Participants
are divided into 1 treatment group

Sponsors and collaborators

VA Office of Research and Development

Lead sponsor

Atlanta VA Medical Center

Collaborator